Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2023 Earnings

Operator: Greetings and welcome to the Marinus Pharmaceuticals' Third Quarter 2023 Financial Results and Business Update Call. [Operator Instructions].

Related Keywords

Texas , United States , Australia , Canada , China , American , Joseph Hulihan , Daniel Gossett , Steven Pfanstiel , Scott Braunstein , Brian Abrahams , Christy Shafer , Christina Shafer , Joe Hulihan , Thomas Lyons , Joseph Thome , Steve Pfanstiel , Sonya Weigle , Marinus Pharmaceuticals Inc , American Epilepsy Society Meeting , Orion Corporation , Exchange Commission , Marinus Access Program , Nasdaq , Part Of Uniphar Group Product Access Division , American Epilepsy Society Annual Meeting , Corporate Affairs , Marinus Pharmaceuticals , Call Transcript November , Marinus Pharmaceutical Third Quarter , Business Update , Senior Vice President , Investor Relations , Human Resources , Chief Executive Officer , Chief Commercial Officer , Chief Business Officer , Chief Medical Officer , Chief Financial Officer , Chief Operating , Drug Evaluation , China National Medical Product Administration , Tenacia Biotechnology , Texas Child Neurology , Investor Day , Access Program , Uniphar Group , Product Access Division , Marinus Access , American Epilepsy Society , Lennox Gastaut Syndrome , Undervalued Dividend Stocks To Buy Now , Dividend Stocks ,